Home / Bio-technology / United States Whole Exome Sequencing Market Report 2016

United States Whole Exome Sequencing Market Report 2016

  • Id : RNR-25410
  • Category : Bio-technology
  • Publish Date : 13-Oct
  • Pages : 118
  • Format : PDF
License Type

Description
Notes:
Sales, means the sales volume of Whole Exome Sequencing
Revenue, means the sales value of Whole Exome Sequencing

This report studies sales (consumption) of Whole Exome Sequencing in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
    Illumina, Inc. (U.S.)
    Life Technologies (acquired by Thermo Fisher Scientific, Inc.) (U.S.)
    Roche NimbleGen, Inc. (U.S.)
    Agilent Technologies (U.S.)
    BGI (Beijing Genomics Institute, China)
    Eurofins Genomics, Inc. (Germany)
    Sengenics (U.S.)
    GENEWIZ, Inc. (U.S.)
    Knome, Inc. (U.S.)
    Macrogen, Inc. (South Korea)
    Ambry Genetics (U.S.)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
    Sequencing by Synthesis
    Ion Semiconductor Sequencing
    Others
Split by applications, this report focuses on sales, market share and growth rate of  Whole Exome Sequencing in each application, can be divided into
    Diagnostics
    Cancer
    Monogenic Disorders
    Diabetes
    Others
    Drug Discovery and Development
    Personalized Medicine
    Agriculture and Animal Research
    Others